Kathiawad Today

Hydroxychloroquine Market Size 2020 Global Analysis, Share, Trend, Demand, Supply, Key Players Production Capacity, Opportunity and Forecast Till 2026

 Breaking News
  • No posts were found

Hydroxychloroquine Market Size 2020 Global Analysis, Share, Trend, Demand, Supply, Key Players Production Capacity, Opportunity and Forecast Till 2026

April 14
10:00 2020
Hydroxychloroquine Market Size 2020 Global Analysis, Share, Trend, Demand, Supply, Key Players Production Capacity, Opportunity and Forecast Till 2026
Hydroxychloroquine Market by Dosage (200 mg, 400 mg, 800 mg), Application {(Coronavirus disease (COVID 19), Porphyria Cutanea Tarda (PCT), Q Fever, Lupus Erythematosus, Malaria, Rheumatoid Arthritis, Others)}, Distribution Channel (Online Pharmacy, Speciality Drug Stores, Hospital Pharmacy, Retail Pharmacy) , By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Trend Analysis, Competitive Market Share & Forecast, 2020-2026

The Global Hydroxychloroquine Market is estimated to grow at a CAGR of 33.47% during the forecast period 2020-2026. As per the analysis, the global market was valued $542.36 million in the year 2019 and is expected to reach $5,415.23 million by the end of the year 2026.

The Global Hydroxychloroquine Market is majorly driven by increasing prevalence of malaria and increasing incidences of autoimmune diseases such as lupus erythematosus and rheumatoid arthritis. Moreover, the global market is majorly influenced by effective usage of hydroxychloroquine drug in the treatment of COVID-19 worldwide.

Download PDF Brochure : https://www.reportocean.com/industry-verticals/sample-request?report_id=BWC90

Segmentation Overview of the Global Hydroxychloroquine Market

The global hydroxychloroquine market has been segmented on the basis of dosage type, application, and distribution channel. These major market segments are further categorized into various sub-segments to study the market in detail.

The Dosage Type Segment of the Global Hydroxychloroquine Market is Sub-Segmented into:

  • 200 mg
  • 400 mg
  • 800 mg

The Application Segment of the Global Hydroxychloroquine Market is Sub-Segmented into:

  • Coronavirus disease (COVID 19)
  • Q fever
  • Porphyria Cutanea Tarda (PCT)
  • Lupus Erythematosus
  • Rheumatoid Arthritis
  • Malaria
  • Others

The Distribution Channel Segment of the Global Hydroxychloroquine Market is Sub-Segmented into:

  • Online Pharmacy
  • Speciality Drug Stores
  • Hospital Pharmacy
  • Retail Pharmacy

Geographical Overview of the Global Hydroxychloroquine Market

The regions analysed in the research study of the global hydroxychloroquine market are North America, Europe, South America, Asia Pacific, and Middle East and Africa. As per the analysis, the Asia Pacific region accounted for the major market share in the global market and North America is estimated to grow at significant CAGR during the forecast period.

In the APAC region, India valued as the largest manufacturer of hydroxychloroquine and accounted to produce more than 70% of the overall world capacity of the drug. The major factor supporting the large-scale production of hydroxychloroquine in the region is high prevalence of malaria in India. Moreover, in current scenario, owing to positive effect of hydroxychloroquine in the treatment of COVID-19 is boosting the demand of drug from around the world and fuelling the production of it in India. Also, the regional growth of the hydroxychloroquine market is highly contributed by China being the largest manufacturer of active pharmaceutical ingredients (APIs) that is used as a major raw material in the production of hydroxychloroquine.

Key Players Insights

Cipla, Macleods Pharmaceuticals, Wallace Pharmaceuticals, Zydus Cadila, Teva Pharmaceutical Industries Ltd., Ipca Laboratories, Sun Pharmaceutical Industries Ltd., Lupin Pharmaceutical, McKesson Corporation, Mylan N.V., Tennessee, Inc., Aphena Pharma Solutions, Covis Pharmaceuticals, Inc., Dr. Reddy’s Laboratories, Concordia Pharmaceuticals Inc., Cardinal Health, Prasco Laboratories, Laurus Labs Limited, Amneal Pharmaceuticals, Inc., Sanofi S.A. and Novartis International AG are some major players included in the research study of the global hydroxychloroquine market. The market players are majorly focusing on geographical expansion, merger and acquisition and product innovation to gain a significant market share.

Target Audience for this Research Report:

  • Platelet-rich Plasma (PRP) Manufacturers and Suppliers
  • Academic Medical Centres & Universities
  • Medical Research Laboratories
  • Business Research & Consulting Service Providers
  • Research & Development (R&D) Companies
  • Hospitals & Clinics
  • Academic Research Institutes

Reasons to Purchase this Research Report

  • The research study offers in-depth demand-supply gap analysis.
  • The research report provides price trends of the global plasma therapy market.
  • The study explains about the production capacity of major market players along with potentials of new market entrants.
  • The study also studies the impact of COVID-19 on the plasma therapy market.

GET FREE SAMPLE COPY @ https://www.reportocean.com/industry-verticals/sample-request?report_id=BWC90

 

Media Contact
Company Name: Report Ocean
Contact Person: Nishi Sharma
Email: Send Email
Phone: +91-9997112116
Address:Classic Tower, Rajnagar Extension
City: Ghaziabad
State: UP, 201017
Country: India
Website: www.reportocean.com